Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response

O. Sibila, C. Agustí, A. Torres, S. Baquero, S. Gando, J. R. Patrón, J. G. Morato, D. H. Goffredo, N. Bassi, C. M. Luna
European Respiratory Journal 2007 30: 1167-1172; DOI: 10.1183/09031936.00053607
O. Sibila
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Agustí
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Torres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Baquero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Gando
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. R. Patrón
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. G. Morato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. H. Goffredo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Bassi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. M. Luna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

An abnormal inflammatory response (IR) in pneumonia is associated with poor outcomes and high mortality. Animal models could help to better understand the relationship between the pulmonary infection and the associated IR. The aims of the present study were to validate an experimental model of pneumonia induced by the inoculation of Pseudomonas aeruginosa in ventilated piglets and to study the associated IR over a long period of time (96 h).

Five Lagerwhite–Landrace piglets were ventilated for 4 days. After intubation, a solution containing 75 mL of P. aeruginosa (106 colony-forming units·mL−1) was bronchoscopically inoculated. Physiological and laboratory parameters were monitored throughout the study. Pro-inflammatory cytokines were measured in serum and in bronchoalveolar lavage (BAL). Histopathology of the lungs and cultures from blood, BAL and lungs were performed.

All the animals developed histopathological evidence of pneumonia. Microbiological studies of both BAL and lung confirmed the presence of P. aeruginosa in all the samples. Throughout the study, an increase in interleukin-6 was observed in serum and in BAL.

In conclusion, the experimental model of pneumonia induced by the inoculation of high concentrations of Pseudomonas aeruginosa in ventilated piglets is feasible and could be appropriate for the evaluation of different aspects of the associated inflammatory response.

  • Experimental pneumonia
  • inflammatory response
  • interleukin-6
  • Pseudomonas aeruginosa
  • ventilated piglets

Patients with severe community- or hospital-acquired pneumonia requiring mechanical ventilation have a very high mortality 1, 2. Over the last 10 yrs, evidence has been collected demonstrating the relevance of the host inflammatory response (IR) in the evolution of bacterial infections. Several studies in severe pneumonia 3, 4 have shown increased levels of different inflammatory cytokines both in the lung and in serum, and recent publications 5, 6 have demonstrated that an increased IR is a strong predictor of nonresponse to treatment and mortality in these patients. In clinical practice, different factors, such as the use of antibiotics or the presence of comorbidities, may influence the local and systemic IR, and the influence of these factors is difficult to assess accurately in humans. Animal models could help to clarify this issue. Marquette et al. 7 have developed an animal model of pneumonia in mechanically ventilated piglets that closely resembles severe human pneumonia. This model has proved to be very useful for the proper evaluation of different aspects regarding diagnosis and treatment 8–13. Pseudomonas aeruginosa is one of the most lethal causative microorganisms both in community-acquired pneumonia and ventilator-acquired pneumonia 1, 2, 6. The incidence of P. aeruginosa pneumonia is increasing and involves patients that usually receive different antibiotics and suffer from diverse comorbidities and associated lung pathologies. These circumstances complicate the interpretation of the associated IR to this invasive microorganism. The availability of an animal model of severe pneumonia where potential confounders are excluded or controlled may improve the current knowledge on the intimal mechanisms involving the associated IR. This animal model has been used for pharmacological studies 13, including the evaluation of the effects of antibiotics 14. In the present study, the clinical and histopathological consequences of P. aeruginosa inoculation were investigated, as well as the characteristics of the associated IR in animals ventilated for long periods of time (96 h).

It was hypothesised that inoculation of high concentrations of P. aeruginosa in ventilated piglets induces severe pneumonia. By doing so and by maintaining piglets ventilated for a long period of time, the histopathological derangement of lung parenchyma, as well as the associated IR, can be investigated. The aims of the present study were to validate an experimental model of pneumonia induced by the inoculation of P. aeruginosa in ventilated piglets and to assess the associated IR in the lung and in serum.

METHODS

An experimental intensive care unit was set up at the Hospital de Clínicas “José de San Martín”, University of Buenos Aires, Buenos Aires, Argentina. It is fully equipped with cardiovascular monitors (model 78353-A; Hewlett-Packard, Andover, MA, USA), ventilators (Monal D; Air Liquide Santé, Paris, France) and electrical infusor pumps (Abbott Laboratories, Abbott Park, IL, USA).

Animal preparation

Six healthy domestic-bred Largewhite–Landrace piglets, aged 3 months and weighing 20±2 kg were anesthetised and orotracheally intubated with a 7.0-mm low-pressure cuff tube (Portex Ltd, Hythe, UK). They were pre-anaesthetised with intramuscular ketamine (Ketalar; Parke-Davis, Lansing, MI, USA) 250 mg. Anaesthesia was maintained with a continuous infusion of midazolam (Dormicum®; Roche, Basel, Switzerland) 0.3 mg·kg−1·h−1, pancuronium bromide (Pavulon© 4 mg; Organon, Buenos Aires, Argentina) 0.32 mg·kg−1·h−1 and phentanyl (Sublimaze© 0.07 mg; Janssen-Cilag, Anvers, Belgium) 5 μg·kg−1·h−1. A catheter was inserted in the femoral vein for continuous infusion of 10% dextrose (1.5 mL·kg−1·h−1) and Ringer lactate (3 mL·kg−1·h−1) with an infusion pump. The femoral artery was cannulated with a 3F polyethylene catheter (Plastimed, St Leu-la-Forêt, France) for pressure monitoring and blood sampling. An 8F suprapubic urinary catheter (Vesicoset; Angiomed, Karlsruhe, Germany) was placed in the bladder through surgical midline minipelvitomy. The piglets were then placed in a prone position and mechanically ventilated. Piglets that died during the first 12 h were excluded from the study.

Mechanical ventilation

Animals were mechanically ventilated in a volume-controlled mode. Ventilator parameters consisted of tidal volume (VT) at a constant inspiratory flow of 10 mL·kg−1, a respiratory frequency (fR) of 15 breaths·min−1, an inspiratory time of 33%, with an initial inspiratory fraction (FI,O2) of 100% and a positive end-expiratory pressure (PEEP) of 0. Later, FI,O2 was set according to blood gas analysis in order to obtain arterial oxygen tension (Pa,O2) ≥80 and <100 mmHg, and PEEP was increased to ≤5 cmH20. Airway pressures, static lung compliance (calculated by dividing VT by the difference between the end-inspiratory plateau pressure and the total PEEP 15) and arterial blood gases (blood gas analyser IL-1306; Instrumentation Laboratories, Milan, Italy) were determined every 6 h. Throughout the protocol, the carbon dioxide arterial tension was maintained at 35–45 mmHg by increasing the fR to the maximum level preceding the appearance of auto-PEEP. Above this limit, hypercapnia was tolerated.

Bronchial inoculation

Animals were inoculated with 75 mL of a suspension of 106 colony-forming units (cfu)·mL−1 of pathogenic P. aeruginosa ATCC 27853. Through the bronchoscope channel, 15 mL of the infusion was evenly distributed among every lobe of each lung.

The inocula of bacteria were instilled once the animals were haemodinamically stable after sedation and mechanical ventilation.

Sampling and procedures

Mechanical ventilation parameters (VT, fR, airway pressures and FI,O2), cardiac frequency, blood pressure, body temperature, blood gases, serum electrolytes (sodium, potassium) and lactate concentrations were monitored at 0, 2, 6, 12, 24, 36, 48, 60, 72, 84 and 96 h. Blood biochemistry (glucose, creatinine, urea, bilirrubin, aspartate aminotransferase and alanine aminotransferase) and blood cells count were obtained at 0, 24, 48, 72 and 96 h.

Bronchoalveolar lavage

Five 20-mL aliquots of sterile saline solution (0.9% sodium chloride) were instilled and re-aspirated through the bronchoscope's channel in the right middle lobe at 0 h (before the inoculation of the P. aeruginosa suspension) and at 96 h.

Inflammatory parameters

C-reactive protein

C-reactive protein (CRP) was quantified in serum and bronchoalveolar lavage (BAL) using a CRP kit (Biosystems S.A., Barcelona, Spain).

Cytokines in blood and BAL fluid

Tumour necrosis factor (TNF)-α and interleukin (IL)-1β, -6 and -8 levels were measured in serum and BAL supernatant using the ELISA method in specific porcine kits (R&D Systems Inc., Minneapolis, MN, USA).

BAL cytokines and CRP were determined at the time of intubation and at the end of the study. Serum cytokines and CRP were determined at the time of intubation and at 24, 48, 72 and 96 h.

Bacteriological studies

Quantitative cultures of BAL fluid, serum and lung tissue were performed at the end of the study.

BAL and lung tissue specimens were processed for quantitative bacterial cultures as described elsewhere 16, according to recommended laboratory methods 17.

Sacrifice and post mortem studies

Sacrifice was performed at 96 h under general anaesthesia by intravenous potassium chloride infusion.

Collection of lung specimens

After death, the animals remained under mechanical ventilation until surgical samples of lung parenchyma were obtained for bacteriological and histopathological evaluation. The lungs were aseptically exposed through a cervicothoracic midline incision. Thereafter, at least one lung tissue specimen (1 cm3) was taken from both the more preserved lobe (macroscopically) and the more involved lobe.

Histopathological assessment

Lung tissue was processed according to standard methods. Analysis of vessels (thrombosis and endothelial lesions) and pleural (acute or chronic pleuritis) and lung parenchyma was performed. The evaluation of lung parenchyma included severity of pneumonia and presence of other associated lesions (hyaline membranes and alveolar damage). Severity of pneumonia was graded according to previously published criteria 18 as follows: 0 = no pneumonia; 1 = purulent mucous plugging; 2 = bronchiolitis; 3 = pneumonia (consolidation coexisting with significant accumulation of polymorphonuclear leukocytes, fibrinous exudates and cellular debris into the alveolar space); 4 = confluent pneumonia (extension along different secondary lobes); and 5 = abscessed pneumonia (cellular necrosis coexisting with disruption of cellular architecture). Pneumonia was limited to the last three categories. Classification of each specimen was based upon the worst category observed.

Statistical analysis

All data were expressed as mean±sd or sem as appropriate. Nonparametric tests for paired data were used; Wilcoxon and Friedman tests were used for comparison of two or more than two time-points, respectively. A p-value <0.05 was considered statistically significant.

Approval by the institutional committee

All animals were treated in compliance with the guidelines of the Ethics Committee and Direction of Investigation of the Hospital de Clínicas “José de San Martín” and the “Guide for the Care and Use of Laboratory Animals” 19.

RESULTS

A total of five piglets were studied after excluding one that died during the first 12 h (death attributable to the animal preparation).

Physiological and laboratory data

Physiological and laboratory variables are shown in table 1⇓. After bronchial inoculation, a rapid and persistent decrease of the Pa,O2/FI,O2 ratio (p = 0.01) and a rise in body temperature (p = 0.03) were observed throughout the study. Static lung compliance decreased over time, although differences did not reach statistical significance. No differences in biochemical data were observed.

View this table:
  • View inline
  • View popup
Table 1—

Sequential measurements of physiological and laboratory parameters

Inflammatory response

Serum IL-6 increased throughout the study, with a maximal increase at 48 h. IL-1β and -8 did not change significantly. Although not significant, levels of TNF-α decreased slightly at the end of the study (fig. 1⇓).

Fig. 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1—

Sequential determination of serum a) interleukin (IL)-1β, b) IL-6, c) IL-8 and d) tumour necrosis factor (TNF)-α during the study. Data are presented as mean±sem. a) p = 0.97, b) p = 0.04, c) p = 0.67 and d) p = 0.30 (calculated according to Friedman test).

A significant increase in the concentration of IL-6 in BAL fluid at the end of the study was also observed. The increase in the concentration of the remaining cytokines evaluated did not reach statistical significance (fig. 2⇓). Levels of CRP in BAL fluid did not change over the study period (data not shown).

Fig. 2—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2—

Bronchoalveolar lavage (BAL) measurements at 0 and 96 h of the initiation of the study of a) interleukin (IL)-1β, b) IL-6, c) IL-8 and d) tumour necrosis factor (TNF)-α. Data are presented as mean±sem. a) p = 0.06, b) p = 0.04, c) p = 0.14 and d) p = 0.46 (calculated according to Wilcoxon test).

Microbiology

P. aeruginosa was present in all samples from BAL fluid and lung tissue cultures from the five piglets evaluated. BAL cultures yielded P. aeruginosa in a concentration >104 cfu·mL−1 in four piglets and >105 cfu·mL−1 in one piglet. Lung tissue cultures also showed growth of P. aeruginosa in a concentration >104 cfu·gr−1 in all the samples evaluated. Blood cultures were positive for P. aeruginosa in one piglet.

Morganella morgani and Staphylococcus coagulase-negative (both in a concentration of 103 cfu·mL−1) were also detected in two and three samples out of 20 evaluated, respectively.

Histopathological findings

All piglets developed pneumonia (grades 3–5). Pneumonia was present in all the samples taken from the most involved lobes and in three out of the five samples taken from the most preserved lobes. Severe pneumonia, defined as abscessed pneumonia or confluent pneumonia (grades 4 and 5), was present in 60% of the pulmonary biopsies and in three out of five piglets (table 2⇓). Acute or subacute pleuritis was also present in all the piglets; diffuse alveolar damage, defined by the presence of hyaline membranes covering the alveolar epithelium was present in four out of five piglets; and vascular lesions, including endothelial or thrombosis, was present in three out of five.

View this table:
  • View inline
  • View popup
Table 2—

Histopathological findings

DISCUSSION

The results of the present study demonstrate that inoculation of P. aeruginosa into the lungs in ventilated piglets causes pneumonia. After a long period of mechanical ventilation (96 h) all the animals developed pneumonia by this microorganism and severe histopathological lesions in the lungs were observed in the majority of piglets. In addition, using this animal model, the present authors were able to evaluate the dynamics of the associated IR, which was characterised by a significant increase in IL-6 levels over time in both serum and BAL.

The availability of an experimental model of severe pneumonia, in which animals are ventilated during 96 h without the interference of antibiotic treatment, allows the physiopathological changes taking place in the lung to be studied throughout the process. Inoculation of P. aeruginosa led to the development of clinical signs of pneumonia (fever and gas exchange impairment) and deterioration in lung mechanics (decrease in static compliance over time). Post mortem evaluation confirmed both histopathologically and microbiologically the presence of pneumonia in all the animals evaluated.

The presence of pneumonia was evident in all the lobes that macroscopically were most involved but also in 60% of the most preserved ones, confirming the multilobar distribution of the infection. Interestingly, there was also evidence of hyaline membranes in 80% of the piglets evaluated. Hyaline membranes appear later in the evolution of pneumonia and their presence is associated with diffuse alveolar damage and irreversible fibrosis 20. Goldstein et al. 9 evaluated lesions associated with acute pneumonia in the same animal model and, as expected, no hyaline membranes or signs of diffuse alveolar damage were observed. By contrast, in the present study, the development of late-stage lesions of pneumonia was common, as animals were ventilated for long periods of time. This circumstance might be useful for the assessment of different types of treatment that have been claimed to be beneficial in these late stages, such as glucocorticoids or other immunomodulators.

In the present study, P. aeruginosa was selected as the aetiological agent, as it is a common and often lethal cause of pneumonia in ventilated patients 2. Patients with P. aeruginosa pneumonia usually receive different types of antibiotics and suffer from several comorbidities, circumstances that may influence the associated IR. By using this animal model of pneumonia, some of the potential confounders were avoided, making the assessment of the IR more accurate.

The lung IR at the end of the study was characterised by an increase in different pro-inflammatory cytokines, mainly IL-6, in BAL fluid. Although an increase in IL-6 levels was also observed in serum, the dynamics of the remaining cytokines evaluated in blood did not show a consistent pattern, suggesting that the IR was mainly compartmentalised. Dehoux et al. 21 confirmed that the production of cytokines in response to local bacterial infection is compartimentalised in a study in humans with unilateral pneumonia. However, when the pneumonia is more severe, causes septic shock or is acquired during mechanical ventilation, the systemic IR is also evident 3, 4, 22. The lack of correlation between local and systemic inflammation and the inconsistent pattern of the different cytokines measured in serum may probably be explained by the absence of sepsis in the animals studied, as reflected by negative blood cultures in all but one animal, no haemodynamic disturbances and no requirement for vasopressive drugs. In the present study, IL-6 was the only of the cytokines evaluated that showed a significant increase (both in serum and in the lung). In fact, correlations between severity scores and serum IL-6 have been observed 23, 24. In addition, IL-6 concentration in serum has been shown to be an independent predictive factor of mortality in different population groups 5, 6. In this sense, measurement of IL-6 concentration in serum and in BAL might be a very useful parameter to assess the magnitude of the IR and the potential effects of different anti-inflammatory treatments.

The present study has limitations. First, the exogenous administration of a highly bacterial inoculum in a previously healthy animal does not necessarily reflect the complexities of pneumonia development in humans. Potential species differences in lung immunology between piglets and humans must also be considered. Also, sequential BAL samples at different time-points would have been optimal for an accurate evaluation of the local IR. Although the “early-phase” cytokines evaluated in the present study have been widely used in clinical practice for the assessment of the IR, other inflammatory mediators, such as adhesion proteins, regulated on activation, normal T-cell expressed and secreted, or IL-10, might have been more appropriate, as they are expressed in more advanced phases of the infection. Finally, the fact that the injury of mechanical ventilation might have played some role in the observed IR cannot be excluded.

In summary, the present animal model of pneumonia by Pseudomonas aeruginosa has proved to be efficacious and reproducible, and may constitute a useful tool for evaluating the inflammatory response associated with pulmonary infections and the potential effects of immunomodulatory treatments.

  • Received May 4, 2007.
  • Accepted August 22, 2007.
  • © ERS Journals Ltd

References

  1. ↵
    Bodí M, Rodríguez A, Solé-Violán J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005;41:1709–1716.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999;27:1745–1753.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Schütte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996;9:1858–1867.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Fernández-Serrano S, Dorca J, Coromines M, Carratalá J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003;10:813–820.
    OpenUrlCrossRefPubMed
  6. ↵
    Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of nonresponse to treatment of the intensive care unit-acquired pneumonia. Crit Care Med 2004;32:938–945.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Marquette CH, Wermert D, Wallet F, Copin MC, Tonnel AB. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999;115:200–209.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Wermert D, Marquette CH, Copin MC, et al. Influence of pulmonary bacteriology and histology on the yield of diagnostic procedures in ventilator-acquired pneumonia. Am J Respir Crit Care Med 1998;158:139–147.
    OpenUrlPubMedWeb of Science
  9. ↵
    Goldstein I, Bughalo MT, Marquette CH, et al. Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets. Am J Respir Crit Care Med 2001;163:958–964.
    OpenUrlPubMedWeb of Science
  10. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002;166:1375–1381.
    OpenUrlCrossRefPubMedWeb of Science
  11. Elman M, Goldstein I, Marquette CH, et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 2002;97:199–206.
    OpenUrlCrossRefPubMedWeb of Science
  12. Ferrari F, Goldstein I, Nieszkowszka A, et al. Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs. Anesthesiology 2003;98:1016–1019.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Tonnellier M, Ferrari F, Goldstein I, Sartorius A, Marquette CH, Rouby JJ. Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 2005;102:995–1000.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Luna CM, Baquero S, Gando S, et al. Experimental severe Pseudomonas aeruginosa pneumonia and antibiotic therapy in piglets receiving mechanical ventilation. Chest 2007;132:523–531.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Rossi A, Polese G, Brandi G, Conti G. Intrinsic positive end-expiratory pressure (PEEPi). Intensive Care Med 1995;21:522–536.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    El-Ebiary M, Torres A, González J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993;148:1552–1557.
    OpenUrlPubMedWeb of Science
  17. ↵
    Balows A, Hausler WJJ. eds. Manual of Clinical Microbiology. 5th Edn. Washington, American Society for Microbiology, 1991
  18. ↵
    Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151:1878–1888.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    US Department of Health and Human Services. Guide for the Care and Use of Laboratory Animals. National Institute of Health Publication No. 93–23, revised 1985
  20. ↵
    Meduri GU, Eltorky M, Winer-Muram HT. The fibroproliferative phase of late adult respiratory distress syndrome. Semin Respir Infect 1995;10:154–175.
    OpenUrlPubMed
  21. ↵
    Dehoux MS, Boutten A, Ostinelli J, et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150:710–716.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Bauer TT, Montón C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000;55:46–52.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Glynn P, Coakley R, Kilgallen I, Murphy N, O’Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999;54:51–55.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002;20:990–995.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 30 Issue 6 Table of Contents
European Respiratory Journal: 30 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
O. Sibila, C. Agustí, A. Torres, S. Baquero, S. Gando, J. R. Patrón, J. G. Morato, D. H. Goffredo, N. Bassi, C. M. Luna
European Respiratory Journal Dec 2007, 30 (6) 1167-1172; DOI: 10.1183/09031936.00053607

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
O. Sibila, C. Agustí, A. Torres, S. Baquero, S. Gando, J. R. Patrón, J. G. Morato, D. H. Goffredo, N. Bassi, C. M. Luna
European Respiratory Journal Dec 2007, 30 (6) 1167-1172; DOI: 10.1183/09031936.00053607
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Determinants of community-acquired pneumonia in children and young adults in primary care
  • Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis
  • Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Show more Original Articles: Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society